Videos

Michael L. Krychman, MD, and Jack D. Sobel, MD, review the mechanisms of ibrexafungerp and how it might fit in the treatment spectrum for RVVC.

Michael L. Krychman, MD, and Jack D. Sobel, MD, review the clinical implications of the recent approval of oteseconazole, which has been shown to be efficacious and well tolerated in RVVC treatment.

Hear from Kimberly Kho, MD, as she discusses her presentation at AAGL's 51st Global Congress on MIGS in Aurora, Colorado regarding alternatives to hysterectomy and uterine-preserving options for fibroids.

Hear from Kimberly Kho, MD, as she discusses her presentation at AAGL's 51st Global Congress on MIGS in Aurora, Colorado regarding alternatives to hysterectomy and uterine-preserving options for fibroids.

Sarah Crafton, MD, details how sentinel lymph node mapping can help identify the stage of uterine cancers and lead to better patient care.

Jeanette Carpenter, MD, MSCI, maternal-fetal medicine specialist at Pediatrix Medical Group, discussed a recently published study regarding pregnant COVID-19 patients who also had disseminated intravascular coagulation (DIC).

Thought leaders discuss the history of RVVC treatment, including the use of unapproved topical antifungals and the shortcomings of fluconazole.

Michael L. Krychman, MD, and Jack D. Sobel, MD, explore avenues for confirming a diagnosis of RVVC, including cultures and molecular testing.

Michael L. Krychman, MD, and Jack D. Sobel, MD, review diagnostic criteria of diagnosis of RVVC and the impact of misdiagnosis.

Michael L. Krychman, MD and Jack D. Sobel, MD, talk about the signs and symptoms of vulvovaginal candidiasis as well as its effect on patient quality of life.

Charlene Gamaldo, MD, discusses patient criteria for selecting a dual orexin receptor agonist (DORA) for insomnia treatment.

An overview of dual orexin receptor agonists (DORAs) therapy for the treatment of insomnia in female patients.

Tracey Vogel, MD, of the Allegheny Health Network, discusses the organization's new Perinatal Trauma-informed Care Clinic, as well as some useful tips for implementing trauma-informed care into your own practice.

Alyssa Dweck, MD, discusses some recent positive data presented at the 2022 NAMS meeting regarding Clairvee (Bonafide Health) as a potential treatment for vaginal odor.

Charlene Gamadelo, MD, describes the different categories of FDA approved treatments for insomnia along with challenges associated with these treatments.

Charlene Gamadelo, MD, provides an overview of commonly utilized insomnia treatment modalities in the treatment of female patients with insomnia.

Alison Cowan, MD, discusses her predictions for women's health trends in 2023.

Nash Moawad, MD, MS, FACOG, FACS, sits down to discuss the recent standardization of Essentials of Minimally Invasive Gynecologic Surgery (EMIGS) training program for minimally invasive gynecologic surgeons and how it's shaping the way this subspecialty delivers care.

An overview of the different roles of health care professionals in the management of female patients suffering from insomnia.

An overview of the impact insomnia can have on female patient’s quality of life and how they communicate sleep disturbance concerns with health care professionals.

Jerry Lowder, MD, AUGS Publications Committee vice-chair, interviews Daniel Biller, MD, the writing group chair of the Research Report document “Developing an Advanced Alternative Payment Model for Stress Urinary Incontinence,” to provide an overview and highlight the findings of the document.

Sit in on a recent discussion between Gina Northington, MD, and Marianna Alperin, MD, co-editors of the ebook from AUGS and the IUA entitled, 'Pelvic Floor: Foundational Science and Mechanistic Insights for a Shared Disease Model.'

A neurology expert describes why women experience insomnia at higher rates than men and how co-occurrence of insomnia with other medical conditions, including psychiatric disorders, can affect occurrence.

Charlene Gamadelo, MD, provides an overview of insomnia and discusses the prevalence by race and gender, the variations in presentation of symptoms in patients, and the pathways involved in sleep wakefulness cycles.

In this interview from the AUGS Publication Committee, listen in as Emily Whitcomb, MD, talks with Ingrid Harm-Ernandes, physical therapist and writing group chair, about the highlights within the Clinical Guidance document, “Assessment of the Pelvic Floor and Associated Musculoskeletal System.”

Watch the latest interview in a series from members of the AUGS Publications Committee to hear from Bobby Garcia, MD, about new perspectives in cosmetic gynecology.

Rebecca Thurston, PhD, sits down to discuss her research presented at the NAMS Annual Meeting on vasomotor symptoms and cardiovascular health.

Katie Huffling, DNP, RN, CNM, FAAN, sits down to discuss highlights of her presentation at the Nurse Practitioners in Women’s Health (NPWH) 25th Annual Conference in Houston, Texas from September 28 to October 2022.

Katie Huffling, DNP, RN, CNM, FAAN, sits down to discuss her presentation at the Nurse Practitioners in Women’s Health (NPWH) 25th Annual Conference in Houston, Texas from September 28 to October 2022.